Home › Cancro alla prostata › Arizona › Phoenix
Studi clinici su Cancro alla prostata a Phoenix, AZ
17 studi su Cancro alla prostata cercano partecipanti presso sedi a Phoenix e dintorni (entro circa 30 miglia). Apri uno studio per vedere chi può partecipare e come contattare il team.
Testo ufficiale dello studio (inglese)
Stai reclutando per uno studio? Mettilo in evidenza in cima alla pagina — $99 per 30 giorni →
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
In reclutamentoStudio osservazionaleVolontari sani benvenuti
- Cancer Center at Saint Joseph's, Phoenix
Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
In reclutamentoFase 2
- Mayo Clinic Hospital in Arizona, Phoenix
This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.
In reclutamentoFase 3
- Ironwood Physicians P.C. dba Ironwood Cancer and Research Centers, Phoenix
A Study of Metastases Free Survival With Saruparib vs Placebo Added to a Standard RT/ADT in Men With High-risk Prostate Cancer With a BRCA Mutation
In reclutamentoFase 3
- Research Site, Phoenix
A Study of GSK5458514 Administered Alone or In Combination With Other Anti-Cancer Agents in Participants With Prostate Cancer
In reclutamentoFase 1/2
- GSK Investigational Site, Phoenix
A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)
In reclutamentoFase 3
- Mayo Clinic in Arizona - Phoenix ( Site 0044), Phoenix
Positron Emission Tomography Using 64Cu-SAR-bisPSMA in Participants With High-risk Prostate Cancer Prior to Radical Prostatectomy
In reclutamentoFase 3
- Mayo Clinic- Phoenix, Phoenix
AZD2265 Compared With Standard of Care in PSMA-positive Metastatic Castration-resistant Prostate Cancer (VECTRA-01)
In reclutamentoFase 3
- Research Site, Phoenix
Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging
In reclutamentoFase 3
- Cancer Center at Saint Joseph's, Phoenix
FOG-001 in Locally Advanced or Metastatic Solid Tumors
In reclutamentoFase 1/2
- Mayo Clinic, Phoenix
Study of JANX007 in Subjects With Metastatic Castration-Resistant Prostate Cancer (ENGAGER-PSMA-01)
In reclutamentoFase 1
- Mayo Clinic, Phoenix
Stereotactic Body Radiation Therapy Plus Immediate or Delayed Androgen Receptor Pathway Inhibitor and Androgen Deprivation Therapy or Salvage Radiation Therapy for the Treatment of Prostate Cancer, DIVINE Trial
In reclutamentoFase 2
- Mayo Clinic in Arizona, Phoenix
Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response
In reclutamentoFase 3
- Cancer Center at Saint Joseph's, Phoenix
A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies
In reclutamentoFase 1/2
- Mayo Clinic, Phoenix
Carboplatin Chemotherapy Before Surgery for People With High-Risk Prostate Cancer and an Inherited BRCA1 or BRCA2 Gene Mutation
In reclutamentoFase 2
- Cancer Center at Saint Joseph's, Phoenix
Understanding of Genetics by Men at Risk for Prostate Cancer
In reclutamentoVolontari sani benvenuti
- Mayo Clinic, Phoenix
Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer
In reclutamentoFase 3
- Cancer Center at Saint Joseph's, Phoenix
Studi su Cancro alla prostata in altre città
- New York City, NY103 studi
- Houston, TX76 studi
- Los Angeles, CA61 studi
- Boston, MA59 studi
- St. Louis, MO46 studi
- Chicago, IL45 studi
- San Francisco, CA45 studi
- Philadelphia, PA44 studi
- Baltimore, MD43 studi
- Nashville, TN42 studi
- Seattle, WA42 studi
- Washington, DC38 studi
Altri studi a Phoenix
- Cancro al seno25 studi
- Cancro colorettale25 studi
- Obesità22 studi
- Cancro del polmone non a piccole cellule20 studi
- Cancro metastatico20 studi
- Insufficienza cardiaca18 studi
- Cancro (tutti i tipi)17 studi
- Mieloma multiplo16 studi
- Cancro pancreatico16 studi
- Malattie cardiovascolari16 studi
- Morbo di Alzheimer15 studi
- Sovrappeso15 studi
Fonte: ClinicalTrials.gov, dati recuperati il 5 ott 2026. Ogni studio stabilisce i propri criteri di idoneità; è il team di ricerca a decidere chi può partecipare.